NEW DEVELOPED AND VALIDATED SPECTROSCOPIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TERBINAFINE HYDROCHLORIDE AND FLUCONAZOLE by THAKUR, BHUMIKA & KUMAR, INDER
 
Original Article 
NEW DEVELOPED AND VALIDATED SPECTROSCOPIC METHOD FOR THE SIMULTANEOUS 
ESTIMATION OF TERBINAFINE HYDROCHLORIDE AND FLUCONAZOLE 
 
BHUMIKA THAKUR1*, INDER KUMAR2 
1*Shiva Institute of Pharmacy, Bilaspur, HP, India, 2School of Pharmacy, Abhilashi University, Mandi, HP, India 
Email: bhumi.thakur26@gmail.com 
Received: 09 Aug 2020, Revised and Accepted: 10 Sep 2020 
ABSTRACT 
Objective: A new, simple, precise, accurate, and reproducible method or simultaneous equation method was developed and validated for the 
simultaneous estimation of terbinafine hydrochloride (TH) and fluconazole (FLZ) in pure form.  
Methods: Simultaneous estimation of terbinafine hydrochloride and fluconazole was estimated by the ultraviolet (UV) spectrophotometry method. 
The method was based on the measurement of absorbance at two wavelengths 222 nm and 239 nm, of terbinafine hydrochloride and fluconazole in 
0.1N HCl respectively.  
Results: Calibration curves terbinafine hydrochloride and fluconazole were found to be linear in the concentration ranges of 0.5-3.0 μg/ml and 80-
400 μg/ml, respectively, with their correlation coefficient values (R2) 0.999 and 0.998. LOD and LOQ of TH were found to be 0.067, 0.203 at 222 nm 
and 0.175, 0.531 at 239 nm, similarly for FLZ; 31.089, 94.210 at 222 nm and 94.380, 286.00 at 239 nm respectively. In the precision study, the % 
RSD value was found within limits (%). The percentage recovery at various concentration levels varied from 98.50 % to 103.96 % for TH and 97.27 
% to 103.83 % for FLZ confirming that the expected method is accurate.  
Conclusion: It could be concluded from the results obtained in the present study that this method for simultaneous estimation of TH and FLZ in 
pure is simple, precise, and economical. The proposed method can be applied successfully for the simultaneous estimation of TH and FLZ in the pure 
and pharmaceutical dosage form. 
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INTRODUCTION 
Terbinafine hydrochloride (TH) is (E)-N,6,6-trimethyl-N-
(naphthalen-1-ylmethyl) hept-2-en-4-yn-1-amine; hydrochloride. It 
is an allylamine, which has a wide spectrum of antifungal activity in 
fungal infections of the hair and skin such as Pityriasis Versicolor. 
Terbinafine, a synthetic allylamine antifungal agent, inhibits 
ergosterol biosynthesis via squalene epoxidase. When exposed to 
terbinafine, fungi accumulate squalene while becoming deficient in 
ergosterol, an essential component of fungal cell membranes [1, 2]. 
The inhibition of squalene epoxidase leads to fungistatic and 
fungicidal action. Terbinafine is an orally and topically active drug 
with primarily fungicidal activity against a broad spectrum of fungi, 
including dermatophytes, filamentous, dimorphic organisms, and 
some yeasts such as Candida parapsilosis [3, 4]. 
Fluconazole (FLZ) is 2-(2,4-difluorophenyl)-1,3-bis(lH-1,2,4-triazo1-
yl)propan-2-ol. Fluconazole is a synthetic triazole with antifungal 
activity. It is a well-established first-line management option for 
both localized and systemic C. albicans infections. Fluconazole is 
used against superficial and systemic candidiasis and in the 
treatment of cryptococcal infections for patients with the acquired 
immunodeficiency syndrome [5, 6]. Fluconazole main targets the 
heme protein, which co-catalyzes cytochrome-P450-dependent 14 
α-demethylation of lanosterol in the last stage of ergosterol 
biosynthesis in fungus. Fluconazole is effective against C. 
albicans infections at a wide range of body sites and tissues, 
irrespective of the patient's immune status [7, 8]. Therefore, the 
present study aims to develop and validate the simultaneous 
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Fig. 1: Structure of (a) terbinafine hydrochloride (b) fluconazole 
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MATERIALS AND METHODS 
Fluconazole and terbinafine hydrochloride were procured from Lark 
Pharmaceuticals, Bhiwandi, India as a gift sample. Hydrochloric acid, 
methanol, and other chemicals and solvents were procured from 
CDH Chemicals, Mumbai, India. All chemicals and solvents were used 
of analytical grade. 
Preformulation studies 
Various preformulation studies were carried out to identify the 
purity of the drug i.e. physical characterization, melting point, 
partition coefficients, solubility, UV, and FTIR studies [9, 10]. 
Determination of absorption maxima (max) and preparation of 
calibration curve 
Absorption maxima (max) of TH in 0.1N HCl  
Standard known concentration solution (3.0 µg/ml in HCl) was 
scanned in the range of 400-200 nm using a UV-visible 
spectrophotometer to get the absorption maxima. 
Preparation of calibration curve of TH in 0.1N HCl  
100 mg of TH was dissolved in 0.1N HCl in the 100 ml volumetric 
flask and a series of concentrations 0.5 µg/ml, 1.0 µg/ml, 1.5 µg/ml, 
2.0 µg/ml, 2.5 µg/ml, 3.0 µg/ml of TH were prepared, and 
absorbance was measured at 222 nm in UV-visible 
spectrophotometer. 
Determination of absorption maxima (max) of FLZ in 0.1N HCl  
Absorption maxima (max) of FLZ was determined in 0.1N HCl by 
scanning the 400 µg/ml solution in a range of 200-400 nm using a 
UV-visible spectrophotometer. 
Preparation of calibration curve of FLZ in 0.1N HCl  
100 mg of FLZ was dissolved in 0.1N HCl in the 100 ml volumetric 
flask a series of concentration, 80 µg/ml, 120 µg/ml, 160 µg/ml, 200 
µg/ml, 240 µg/ml, 280 µg/ml, 320 µg/ml, 360 µg/ml and 400 µg/ml 
of FLZ were prepared and absorbance was measured at 260 nm. 
Compatibility studies 
Both the drugs were uniformly mixed with dry powdered KBr in the 
ratio of 1:100 and the mixture was then compressed into the 
transparent disc under high pressure using special dies. The disc 
was placed in the FTIR spectrophotometer and the spectrum was 
recorded [11, 12]. 
Development and validation of simultaneous estimation 
method for TH and FLZ by UV-visible spectrophotometer 
Q-Analysis method was developed and validated for the 
simultaneous estimation of TH and FLZ by UV-visible 
spectrophotometer 
Standard stock solutions of TH and FLZ 
Accurately weighed 100 mg of TH was dissolved in 0.1N HCl in 100 
ml volumetric flask. The solution was sonicated for 10 min and the 
final volume was made up with the same solvent. From the standard 
stock solution, pipetting out 1 ml and dissolved it with 0.1N HCl to 
prepare the working standard solution of 100 µg/ml. Then, a series 
of concentrations were prepared using 0.5 ml, 1.0 ml, 1.5 ml, 2.0 ml, 
2.5 ml, and 3.0 ml working standard solution in 10 ml volumetric 
flasks. 
The FLZ standard solution was prepared by weighed 100 mg of drug 
and dissolved in 0.1N HCl in 100 ml volumetric flask for 10 min 
sonication and make up the final volume. From the above solution 
0.8 ml, 1.2 ml, 1.6 ml, 2.0 ml, 2.4 ml, 2.8 ml, 3.2 ml, 3.6 ml, and 4.0 ml 
were pipetted out in series of 10 ml volumetric flask and volume 
was made up with 0.1N HCl.  
Selection of wavelength of maximum absorbance (max) 
3.0 µg/ml solution was prepared from the working stock solution of 
TH in a 10 ml volumetric flask. For FLZ, 400 µg/ml solution was 
prepared by a standard stock solution of FLZ in a 10 ml volumetric 
flask. Both the solutions were scanned in 400-200 nm against 0.1N 
HCl as blank using a UV-visible spectrophotometer.  
Determination of iso-absorptive point 
1.5 µg/ml solution of TH and 200 µg/ml of FLZ and scanning in 
spectrum mode in the range of 400-200 nm. An overlain spectrum of 
TH and FLZ was found and an iso-absorptive point was determined 
[13, 14]. 
Linearity range 
Linearity of TH and FLZ was determined by preparing different 
concentrations i.e. 0.5 µg/ml, 1.0 µg/ml, 1.5 µg/ml, 2.0 µg/ml, 2.5 µg/ml 
and 3.0 µg/ml for TH and 160 µg/ml, 200 µg/ml, 240 µg/ml, 300 µg/ml, 
360 µg/ml and 400 µg/ml for FLZ from their working standard solution 
and absorbance was measured at 222 nm and 239 nm [15]. 
Accuracy  
2.0 µg/ml, 2.5 µg/ml, 3.0 µg/ml and 240 µg/ml, 300 µg/ml, 360 
µg/ml solutions were prepared for TH and FLZ, respectively. These 
were the three different levels 80 %, 100 %, and 120 % by 
considering 2.5 µg/ml and 300 µg/ml as 100 % for TH and FLZ, 
respectively. The recovery study was performed three times at each 
level [16]. 
Intra-day and inter-day precision 
The intra-day and the inter-day precision study was performed by 
preparing the dilution of 2.0 µg/ml, 2.5 µg/ml, 3.0 µg/ml for TH and 
240 µg/ml, 300 µg/ml and 360 µg/ml for FLZ and from the 
respective stock solutions for both the drugs, respectively and 
recording their absorbance at 222 nm and 239 nm against 0.1N HCl 
as a blank. The absorbance of these concentrations was measured 
three times a day at regular intervals of one hour for intra-day and 
day1, day 2, and day 3 for inter-day study [17, 18].  
Repeatability  
3.0 µg/ml and 240 µg/ml of concentrations were prepared from the 
stock solution of TH and FLZ, and absorbance was measured at 222 
nm and 239 nm against 0.1N HCl as a blank. The standard deviation 
and relative standard deviation was calculated [19]. 
Reproducibility 
2.0 µg/ml and 300 µg/ml solutions were prepared separately from 
stock solutions of TH and FLZ and analyzed by one analyst 
(analyst1) at 222 nm and 239 nm. The same solutions were 
prepared by another analyst (analyst2) and values obtained were 
evaluated using a t-test to verify their reproducibility [20, 21]. 
Limit of detection (LOD)  
The limit of detection was calculated from the data obtained from 
the linearity studies. The slope of the linearity plot was determined 
and calculated by the following formula. 
LOD = 3.3 S b   
Where S is the standard deviation of the residuals around the 
regression line. 
b is the slope of the regression line. 
Limit of quantitation (LOQ)  
The LOQ is the lowest concentration of an analyte in a sample that 
can be determined with acceptable precision and accuracy under the 
stated conditions of the test [22-24]. The limit of quantitation can be 
calculated from the standard deviation of the response and the 
slope.  
LOQ = 10 S b   
Where S is the standard deviation of the residuals around the 
regression line. 
b is the slope of the regression line. 
 
RESULTS AND DISCUSSION 
Preformulation studies 
Determination of max and preparation of calibration curve
Determination of absorption maxima (λ max
0.1N HCl 
The absorption maxima of TH and FLZ were found at 222 nm and 
260 nm respectively (fig. 2). The correlation coefficient, intercept
and slope for the calibration data for TH and FLZ also were 
calculated (table 1). 
Compatibility study of TH and FLZ 
For respective functional groups, the important peaks of TH and FLZ 
were present in the spectrum (fig. 4 and table 2). It concludes that 
the TH and FLZ are compatible with each other.
Development and validation of simultaneous estimation method of 
TH and FLZ by UV-visible spectrophotometer 
 
(a)        
Table 1: Calibration curve data of TH and FLZ in 0.1N HCl
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*mean±SD; n=3, SD= standard deviation, TH= terbinafine hydrochloride, FLZ= fluconazole
 
Fig. 3: Calibration curve of TH (left) and FLZ (right) in 
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Selection of wavelength of maximum absorbance (
wavelength  
TH and FLZ showed wavelength maximums at 222 nm and 260 nm 
in 0.1N HCl respectively as shown in fig. 2.
Determination of iso-absorptive point
1.5 µg/ml solution of TH and 200 µg/ml of FLZ were scanned in 
spectrum mode 200-400 nm and the overlain spectrum was f
and it shows an iso-absorptive point at 239 nm as shown in fig. 5.
Results of validation parameters of simultaneous estimation 
method of TH and FLZ by UV-
Linearity curve  
The linearity curve for TH was constructed by 
versus absorbance (fig. 6). The linearity of TH was found in a 
concentration range of 0.5-3.0 µg/ml at 222 nm and 239 nm. The 
linearity of FLZ was found in the concentration range 160
µg/ml at 222 nm and 239 nm. A linear graph wa
absorbance and concentration in the range given in table 3.
       (b) 
Fig. 2: UV spectra of (a) TH (b) FLZ in 0.1N HCl 
 
 





















visible spectrophotometer  
plotting concentration 
-400 

































Table 3: Linearity data of TH and FLZ at 222 nm, 239 nm
Conc. (µg/ml) Conc. (µg/ml) Absorbance at 







*mean±SD; n=3, SD= standard deviation, TH= terbinafine 
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Fig. 4: FTIR spectra of a mixture of TH and FLZ 
a mixture of TH and FLZ 













Fig. 5: Overlain spectra of TH and FLZ in 0.1N HCl 
, and in 0.1N HCl
222 nm Absorbance at 239 nm Absorbance at 222 nm
FLZ 
 0.035±0.0010 0.265±0.0005 
 0.077±0.0015 0.334±0.0012 
 0.102±0.0006 0.431±.0010 
 0.140±0.0012 0.524±0.0005 
 0.178±0.0010 0.628±0.0015 
 0.217±0.0012 0.717±0.0012 
















Fig. 6: Linearity curve of TH and FLZ at 222 nm
Accuracy  
Accuracy results obtained in table 4 showed excellent mean 
recovery percent values, close to 100 %, and low standard deviation 
 





















































*mean±SD, n=3, SD= standard deviation, %Recov 
TH= terbinafine hydrochloride, FLZ= fluconazole
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(a)     (b) 
      (d) 
 and 239 nm in 0.1N HCl by Q-Analysis method, (a) TH at 222
at 222 nm (d) FLZ at 239 nm 
 
values (SD<1.0) which indicate high accuracy of the proposed 
analytical methods. Percent recovery of TH w
98.50 %-103.96 % and FLZ it was found between 97.27
in all recovery level and both wavelengths.
-Analysis method
 % RSD % Recov 
 
Abs Mean
































FLZ at 239 nm 


















 nm (b) TH at 239 nm (c) FLZ 
as found in between of 
 %-103.83 % 
 
 






 0.341 100% 
 0.805 99.90% 
 0.588 101.19% 
 0.769 100% 
 0.955 103.83% 
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Intermediate precision (Intra-day and inter-day precision) 
Intra-day and inter-day precision were assessed using triplicate 
analysis of three different concentrations. The calculated relative 
standard deviation values were found to be very small below 2 % 
indicating good repeatability and reliability of the proposed 
methods. The results and their statistical analysis are summarized in 
table 5. 
 
Table 5: Intraday and interday precision of TH and FLZ at 222 nm and 239 nm 
Conc. 
(µg/ml) 
Intra-day % RSD Inter-day % RSD Intra-day % RSD Inter-day % RSD 
TH Absorbance at 222 nm Absorbance at 239 nm 
2.0 0.646±0.0017 0.216 0.641±0.0031 0.483 0.146±0.0012 0.822 0.144±0.0010 0.694 
2.5 0.790±0.0045 0.569 0.790±0.0015 0.189 0.181±0.0012 0.662 0.182±0.0035 0.019 
3.0 0.911±0.0064 0.702 0.917±0.0031 0.338 0.216±0.0006 0.277 0.217±0.0010 0.555 
FLZ Absorbance at 222 nm Absorbance at 239 nm 
240 0.450±0.0023 0.511 0.454±0.0021 0.465 0.104±0.0006 0.576 0.108±0.0006 0.555 
300 0.562±0.0015 0.267 0.556±0.0010 0.180 0.129±0.00058 0.387 0.127±0.0012 0.945 
360 0.658±0.0023 0.349 0.656±0.0015 0.229 0.154±0.0012 0.779 0.152±0.0010 0.658 
*mean±SD; n=3, SD= standard deviation, %RSD= relative standard deviation, conc= concentration, TH= terbinafine hydrochloride, FLZ= fluconazole  
 
Repeatability 
The repeatability result indicates the precision under the same 
operating conditions over a short interval of time and % RSD was 
found less than 2 % which indicates good repeatability. % RSD was 
in the range of 0.016-0.0193 %, which were less than the standard 
value and show significant results (table 6). 
Reproducibility 
For the proposed method, the t-value found from the t-test indicates 
good reproducibility, and results are shown in table 7. The T-value 
of both the drugs was 0.8857, 0.4000 at 222 nm, and 239 nm in TH, 
wherein FLZ was 0.8000, 0.5066 respectively. Both the drug shows 
no significant difference. 
 




3 µg/ml 3 µg/ml 300 µg/ml 300 µg/ml 
Abs at 222 nm Abs at 239 nm Abs at 222 nm Abs at 239 nm 
1 0.948 0.217 0.561 0.129 
2 0.914 0.219 0.562 0.129 
3 0.915 0.218 0.564 0.128 
4 0.904 0.209 0.564 0.128 
5 0.920 0.221 0.560 0.128 
6 0.916 0.219 0.557 0.125 
Mean 0.918±0.015 0.217±0.0042 0.561±0.0027 0.128±0.0015 
% RSD 0.016 0.0193 0.481 0.0171 
*mean±SD; n= 6, SD= standard deviation, %RSD= relative standard deviation, Conc= concentration, Abs= absorbance, TH= terbinafine 
hydrochloride, FLZ= fluconazole  
 
Table 7: Reproducibility data for TH at 222 nm by Q-Analysis method 
Analyst 1 Analyst 2 t-value Inference Analyst 1 Analyst 2 t-value Inference 
TH at 222 nm (2.0 μg/ml) TH at 239 nm (2.0 μg/ml) 
0.643±0.0015 0.646±0.0030 0.8857 No significant difference 0.145±0.038 0.149±0.0035 0.4000 No significant difference 
FLZ at 222 nm (300 μg/ml) FLZ at 239 nm (300 μg/ml) 
0.566±0.0020 0.565±0.0040 0.8000 No significant difference 0.126±0.0025 0.128±0.0026 0.5066 No significant difference 
*mean±SD; n=3, SD= standard deviation, TH= terbinafine hydrochloride, FLZ= fluconazole  
 
Table 8: LOD and LOQ for TH and FLZ at 222 nm and 239 nm 
Wavelength 222 nm 239 nm 222 nm 239 nm 
Drugs TH FLZ 
LOD (µg/ml) 0.067 0.175 31.089 94.380 
LOQ (µg/ml) 0.203 0.531 94.210 286.00 
Mean of Residual values 0.00020 0.000074 0.001619 0.001034 
*LOD= limit of detection, LOQ= limit of quantification, TH= terbinafine hydrochloride, FLZ= fluconazole 
 
Limit of detection (LOD) and limit of quantitation (LOQ) 
The limit of detection and limit of quantitation was calculated from 
the linearity curve of TH and FLZ at 222 nm and 239 nm. LOD and 
LOQ of TH were found to be 0.067, 0.203 at 222 nm and 0.175, 0.531 
at 239 nm, similarly for FLZ; 31.089, 94.210 at 222 nm and 94.380, 
286.00 at 239 nm respectively (table 8). 
DISCUSSION 
A new, simple, precise, accurate, and reproducible method or 
simultaneous equation method was developed and validated for the 
simultaneous estimation of terbinafine hydrochloride (TH) and 
fluconazole (FLZ) in pure form. The absorption maxima of TH and 
FLZ were found at 222 nm and 260 nm respectively. It shows an iso-
Thakur et al. 
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absorptive point at 239 nm. Compatibility studies show that both 
the drugs were compatible with each other. The linearity of TH was 
found in a concentration range of 0.5-3.0 µg/ml at 222 nm and 239 
nm and the linearity of FLZ was found in the concentration range 
160-400 µg/ml at 222 nm and 239 nm. Percent recovery of TH was 
found in between of 98.50 %-103.96 % and FLZ it was found 
between 97.27 %-103.83 % in all recovery level and both 
wavelengths. Percent recovery of TH and FLZ at all levels were 
found within the specific limit, which revealed that the method is 
accurate. The repeatability result indicates the precision under the 
same operating conditions over a short interval of time and % RSD 
was found less than 2 % which indicates good repeatability. Interday 
and intraday precision studies were also within the specific limits, 
which depicts that method is correct. The T-value of both the drugs 
was 0.8857, 0.4000 at 222 nm, and 239 nm in TH, wherein FLZ was 
0.8000, 0.5066 respectively [23]. Both the drug shows no significant 
difference. LOD and LOQ of TH were found to be 0.067, 0.203 at 222 
nm and 0.175, 0.531 at 239 nm, similarly for FLZ; 31.089, 94.210 at 
222 nm and 94.380, 286.00 at 239 nm respectively [25]. All the 
parameters were done as per the ICH guidelines.  
CONCLUSION 
Simultaneous estimation of fluconazole and terbinafine 
hydrochloride was developed and validated by UV-visible 
spectroscopy. All the statically analyses were within the standard 
limits. It proves that the method was repeatable and selective for the 
simultaneous estimation of TH and FLZ in pure and that it can be 
successfully used for simultaneous estimation of TH and FLZ in 
pharmaceutical dosage forms. The developed method was found to 
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